🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Prospective multicenter study in which all patients with borderline or loca...
Status
Recruiting
Location
Hospital General de Alicante
Start Date
2024-03-21
Trial ID
NCT06582342
The goal of this interventional clinical trial is to compare the efficacy o...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-24
Trial ID
NCT07413146
This is a phase II, single-arm, open-label study to evaluate the efficacy a...
Status
Unknown
Location
Shanghai Pulmonary Hospital
Start Date
2021-01-31
Trial ID
NCT04667793
Treatments Being Tested
This study aims to evaluate the efficacy of adjuvant docetaxel chemotherapy...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2019-09-01
Trial ID
NCT06864533
Treatments Being Tested
Surgical resection is the only potentially curative treatment for patients ...
Status
Terminated
Location
Smilow Cancer Hospital
Start Date
2017-06-26
Trial ID
NCT03099265
Treatments Being Tested
To explore the efficiency and safety of Tislelizumab combinated with carbop...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT06366945
(1) Evaluate the efficacy of apatinib in combination with standard second-l...
Status
Unknown
Location
Multiple Locations
Start Date
2018-02-28
Trial ID
NCT03412994
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of chemoth...
Status
Unknown
Location
Affiliated Tumor Hospital of Guangzhou Medical University
Start Date
2016-02
Trial ID
NCT02651441
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Status
Recruiting
Location
Shanghai Cancer Center
Start Date
2024-01-10
Trial ID
NCT06149689
Treatments Being Tested
VALENTINE is a parallel, non-comparative, three-arm, randomized 1:2:2 open-...
Status
Active Not Recruiting
Location
ICO Badalona
Start Date
2022-11-25
Trial ID
NCT05569811
Treatments Being Tested